BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27096301)

  • 41. rMAPS: RNA map analysis and plotting server for alternative exon regulation.
    Park JW; Jung S; Rouchka EC; Tseng YT; Xing Y
    Nucleic Acids Res; 2016 Jul; 44(W1):W333-8. PubMed ID: 27174931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nova autoregulation reveals dual functions in neuronal splicing.
    Dredge BK; Stefani G; Engelhard CC; Darnell RB
    EMBO J; 2005 Apr; 24(8):1608-20. PubMed ID: 15933722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.
    Makeyev EV; Zhang J; Carrasco MA; Maniatis T
    Mol Cell; 2007 Aug; 27(3):435-48. PubMed ID: 17679093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SRSF10 Plays a Role in Myoblast Differentiation and Glucose Production via Regulation of Alternative Splicing.
    Wei N; Cheng Y; Wang Z; Liu Y; Luo C; Liu L; Chen L; Xie Z; Lu Y; Feng Y
    Cell Rep; 2015 Nov; 13(8):1647-57. PubMed ID: 26586428
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.
    Ramalingam S; Ramamoorthy P; Subramaniam D; Anant S
    Immunogastroenterology; 2012; 1(1):27-33. PubMed ID: 23795348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells.
    Moulton VR; Gillooly AR; Perl MA; Markopoulou A; Tsokos GC
    PLoS One; 2015; 10(7):e0131073. PubMed ID: 26134847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review).
    Li J; Xian L; Zhu Z; Wang Y; Zhang W; Zheng R; Xue W; Li J
    Int J Mol Med; 2023 Oct; 52(4):. PubMed ID: 37594127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
    Selvanathan SP; Graham GT; Erkizan HV; Dirksen U; Natarajan TG; Dakic A; Yu S; Liu X; Paulsen MT; Ljungman ME; Wu CH; Lawlor ER; Üren A; Toretsky JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1307-16. PubMed ID: 25737553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA.
    Sutherland LC; Thibault P; Durand M; Lapointe E; Knee JM; Beauvais A; Kalatskaya I; Hunt SC; Loiselle JJ; Roy JG; Tessier SJ; Ybazeta G; Stein L; Kothary R; Klinck R; Chabot B
    BMC Mol Biol; 2017 Jul; 18(1):19. PubMed ID: 28728573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B.
    Guo Q; Wu Y; Guo X; Cao L; Xu F; Zhao H; Zhu J; Wen H; Ju X; Wu X
    Mol Ther Nucleic Acids; 2021 Mar; 23():169-184. PubMed ID: 33335801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements.
    Rieger MA; King DM; Crosby H; Liu Y; Cohen BA; Dougherty JD
    Cell Rep; 2020 Dec; 33(12):108531. PubMed ID: 33357440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of CELF2 promotes skin tumorigenesis and increases drug resistance.
    Sah B; Singh J; Shen Y; Goldfarb N; Samie FH; Geskin LJ; Liu L
    Int J Dermatol; 2024 Jun; ():. PubMed ID: 38887832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retraction Note: GAS5 knockdown alleviates spinal cord injury by reducing VAV1 expression via RNA binding protein CELF2.
    Wang D; Xu X; Pan J; Zhao S; Li Y; Wang Z; Yang J; Zhang X; Wang Y; Liu M
    Sci Rep; 2022 Dec; 12(1):21991. PubMed ID: 36539521
    [No Abstract]   [Full Text] [Related]  

  • 55. Erratum: RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1.
    Zhou L; Xie X
    Exp Ther Med; 2022 Mar; 23(3):245. PubMed ID: 35222722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sp(l)icing up PepR signalling.
    Wirthmueller L; Romeis T
    Nat Plants; 2020 Aug; 6(8):912-913. PubMed ID: 32690889
    [No Abstract]   [Full Text] [Related]  

  • 57. RNA splicing: Layered regulation.
    Seton-Rogers S
    Nat Rev Cancer; 2012 Nov; 12(11):736-7. PubMed ID: 23076160
    [No Abstract]   [Full Text] [Related]  

  • 58. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes.
    Gazzara MR; Mallory MJ; Roytenberg R; Lindberg JP; Jha A; Lynch KW; Barash Y
    Genome Res; 2017 Aug; 27(8):1360-1370. PubMed ID: 28512194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rbfox Proteins Regulate Splicing as Part of a Large Multiprotein Complex LASR.
    Damianov A; Ying Y; Lin CH; Lee JA; Tran D; Vashisht AA; Bahrami-Samani E; Xing Y; Martin KC; Wohlschlegel JA; Black DL
    Cell; 2016 Apr; 165(3):606-19. PubMed ID: 27104978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coupling of RNA Polymerase II Transcription Elongation with Pre-mRNA Splicing.
    Saldi T; Cortazar MA; Sheridan RM; Bentley DL
    J Mol Biol; 2016 Jun; 428(12):2623-2635. PubMed ID: 27107644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.